p53 and Rb1 protein expression: Are they prognostically useful in colorectal cancer?

British Journal of Cancer

Volumn 75, Issue 1, 1997, Pages 87-93

  Poller, D N ^a,b   Baxter, K J ^a   Shepherd, N A ^a  

^a GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^b QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

Cell cycle associated protein; Colorectal cancer; p53; Prognosis; Rb1

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CLINICAL TRIAL; COLORECTAL CANCER; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0031012326     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.14     Document Type: Article

References (36)

1. Auvinen A, Isola J, Visakorpi T, Koivula T, Virtanen S and Hakama M (1994) Overexpression of p53 and long-term survival in colon carcinoma. Br J Cancer 70: 293-296
2. Baas IO, Mulder JW, Offerhaus GJ, Vogelstein B and Hamilton SR (1994) An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J Pathol 172: 5-12
3. Baas IQ, Van Den Berg FM, Mulder JW, Clement MJ, Slebos RJC, Hamilton SR and Offerhaus GJA (1996) Potential false-positive results with antigen enhancement for immunohistochemistry of the p53 gene product in colorectal neoplasms. J Pathol 178: 264-267
4. Bell SM, Scott N, Cross D, Sagar P, Lewis FA, Blair GA, Taylor GR, Dixon MF and Quirke P (1993) Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 104: 57-64
5. Bertorelle R, Esposito G, Mistro AD, Belluco C, Nitti D, Lise M and Bianchi LC (1995) Association of p53 gene and protein alterations with metastases in colorectal cancer. Am J Surg Pathol 19: 463-471
6. Cance WG, Brennan MF, Dudas ME, Huang CM and Cardo CC (1990) Altered expression of the retinoblastoma gene product in human sarcomas. N Engl J Med 323: 1457-1462
7. Cox DR (1972) Regression models and life tables. JR Stat Soc B 34: 187-220
8. Dunn JM, Hastrich DJ, Newcomb P, Webb JC, Maitland NJ and Farndon JR (1993) Correlation between p53 mutations and antibody staining in breast carcinoma. Br J Surg 80: 1410-1413
9. Fearon ER and Vogelstein B (1990) A genetic model for colorectal tumourigenesis. Cell 61: 759-767
10. Goh HS, Chan CS, Khine K and Smith DR (1994) p53 and behaviour of colorectal cancer. Lancet 344: 233-234
11. Hamelin R, Puig-Laurent P, Olschwang S, Jego N, Asselain B, Remvikos Y, Girodet J, Salmon RJ and Thomas G (1994) Association of p53 mutations with short survival in colorectal cancer. Gastroentorology 106: 42-48
12. Iggo R, Gatter K, Bartek J, Lane D and Harris AL (1990) Increased expression of mutant forms of p53 oncogene in primary lung cancer. Lancet 335: 675-679
13. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW and Vogelstein B (1992) Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256: 827-830
14. Kocialkowski S, Pezzella F, Morrison H, Jones M, Laha S, Harris AL, Mason DY and Gatter KC (1995) Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma. Br J Haematol 89: 55-60
15. Lemoine NR (1994) Molecular biology of breast cancer. Ann Oncol 4: 31-37
16. Mantel N (1996) Evaluation of survival time data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170
17. McKee PH, Hobbs C and Hall PA (1993) Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds. Histopathology 23: 377-379
18. McManus DT, Yap EP, Maxwell P, Russell SE, Toner PG and McGee JO (1994) p53 expression, mutation, and allelic deletion in ovarian cancer. J Pathol 174: 159-168
19. Michalovitz D, Halevy O and Oren M (1990) Conditional inhibition of transformation and of cell proliferation by a temperature sensitive mutant of p53. Cell 62: 671-680
20. Mulder JWR, Baas IO, Polak MM, Goodman SN and Offerhaus GJA (1995) Evaluation of p53 protein expression as a marker for long term prognosis in colorectal carcinoma. Br J Cancer 71: 1257-1262
21. Nathanson SD, Linden MD, Tender P, Zarbo RJ, Jacobsen G and Nelson LT (1994) Relationship among p53, stage, and prognosis of large bowel cancer. Dis Colon Rectum 37: 527-534
22. Nylander K, Nilsson P, Mehle C and Roos G (1995) p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck. Br J Cancer 71: 826-830
23. Ofner D, Maier H, Riedmann B, Holzberger P, Nogler M, Totsch M, Bankfalvi A, Winde G, Bocker W and Schmid KW (1995) Immunohistochemically detectable p53 and mdm-2 oncoprotein expression in colorectal carcinoma: prognostic significance. J Clin Pathol. Mol Pathol 48: 12-16
24. Remvikos Y, Tominaga O, Hammel P, Puig-Laurent P, Salmon RJ, Dutrillaux B and Thomas G (1992) Increased p53 protein content of colorectal tumours correlates with poor survival, Br J Cancer 66: 758-764
25. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF and Quirke P (1991) p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 63: 317-319
26. Shepherd NA, Baxter KJ and Love SB (1995) Influence of local peritoneal involvement on pelvic recurrence and prognosis in rectal cancer. J Clin Pathol 48: 849-855
27. Sherr CJ (1994) Growth factor-regulated GI cyclins. Stem Cells 12: 47-55
28. Smith ML, Chen IT, Zhan Q, Bae I, Chen CY, Gilmer TM, Kastan MB, O'Connor PM and Fornace AJ (1994) Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266: 1376-1380
29. Starzynska T, Bromley M, Ghosh A and Stern PL (1992) Prognostic significance of p53 overexpression in gastric and colorectal cancer. Br J Cancer 66: 558-562
30. Sun XF, Carstensen JM, Zhang H, Stal O, Wingren S, Hatschek T and Nordenskjold B (1992) Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 340: 1369-1373
31. Sun XF, Carstensen JM, Stal O, Zhang H, Nilsson E, Sjodahl R and Nordenskjold B (1993) Prognostic significance of p53 expression in relation to DNA ploidy in colorectal adenocarcinoma. Virchows Archiv A Pathol Anat 423: 443-448
32. Vojtesek B, Bartek J and Midgeley CA (1992) An immunochemical analysis of the human nuclear phosphoprotein p53: new monoclonal antibodies and epitope mapping using recombination p53. J Immunol Methods 151: 237-242
33. Yamaguchi A, Kurosaka Y, Fushida S, Kanno M, Yonemura Y, Miwa K and Miyazaki I (1992) Expression of p53 protein in colorectal cancer and its relationship to short term prognosis. Cancer 70: 2778-2784
34. Yamaguchi A, Nakagawara G, Kurosaka Y, Nishimura G, Yonemura Y and Miyazaki I (1993) p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer and its prognostic significance. Br J Cancer 68: 399-402
35. Yamamoto H, Monden T, Ikeda K, Izawa H, Fukuda K, Fukunaga M, Tomita N, Shimuno T, Shiozaki H and Monden M (1995) Co-expression of cdk/cdc2 and retinoblastoma gene products in colorectal cancer. Br J Cancer 71: 1231-1236
36. Zeng ZS, Sarkis AS, Zhang ZF, Klimstra DS, Charytonowicz E, Guillem JG, Cardo CC and Cohen AM (1994) p53 nuclear overexpression: an independent predictor of survival in lymph node-positive colorectal cancer patients. J Clin Oncol 12: 2043-2050